European Cardiology Review
European Cardiology Review (ECR) is a bi-annual journal that undergoes peer review and includes a range of content such as review articles, editorials, and case studies. It presents well-rounded and thorough articles crafted by top experts in the field, focusing on significant advancements in cardiovascular medicine and practice. Under the leadership of Editor-in-Chief Juan Carlos Kaski and supported by a team of Associate Editors and an esteemed editorial board of highly regarded physicians, ECR publishes peer-reviewed work that seeks to deliver timely insights into the most relevant topics in cardiology.
Outlet metrics
Global
#609813
United States
#540087
Health/Medicine
#3554
Articles
-
1 week ago |
radcliffecardiology.com | Kieran F. Docherty |Clara Saldarriaga |Gianluigi Savarese
Learning Objectives Discuss why getting cardiorenal patients onto GDMT is challenging Recall the residual risk posed by the co-existence of heart failure and chronic kidney disease Adopt practical approaches to managing cardiorenal patients based on examples explored during this activity Detail gaps in current standards of care for cardiorenal patients Discuss ongoing efforts aimed at addressing residual risk, hyperkalaemia and clinical inertia in cardiorenal disease Target Audience...
-
2 weeks ago |
radcliffecardiology.com | Jonathan Byrne |Jonathan Curio |Michael G. Mullen |Patrick W. Serruys
EuroPCR 25 - Real-world findings from the REVEAL-AFMR registry show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR). We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from the REVEAL-AFMR registry to investigate the impact of TEER on prognosis in patients with AFMR.
-
Feb 28, 2025 |
radcliffecardiology.com | Gurleen Kaur |Saman Nematollahi |Thomas Das
Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
-
Feb 20, 2025 |
radcliffecardiology.com | Weijian Huang |Pablo Vazquez
Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
-
Feb 20, 2025 |
radcliffecardiology.com | Pablo Vazquez |Marat Fudim |Barry A. Borlaug |Alexander Sullivan
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →